Literature DB >> 3966165

Cheyne-Stokes breathing during sleep in patients with left ventricular heart failure.

L J Findley, C W Zwillich, S Ancoli-Israel, D Kripke, G Tisi, K M Moser.   

Abstract

Fifteen patients with left ventricular heart failure (LVF) without known breathing disorders during sleep had full-night recordings of sleep and breathing to study the incidence and impact of the apnea of Cheyne-Stokes breathing. This group showed a marked degree of sleep-related breathing abnormalities, 40% demonstrating Cheyne-Stokes breathing with five or more central apneas per hour of sleep. Cheyne-Stokes breathing during sleep in patients with LVF predicted an increased short-term mortality rate. All six patients with LVF and Cheyne-Stokes breathing with more than five apneas per hour of sleep were dead within six months, while only three of nine patients without recurrent apnea died within six months, a significant difference (P less than .05) even in this small group. Among seven patients with LVF studied with the polysomnogram, there were statistically significant differences between the Cheyne-Stokes and non-apnea groups in total sleep time, awakening per hour, and the number of arterial desaturations. Although sleep disturbances have been anecdotally described in patients with LVF, no previous investigation has determined the incidence and impact of Cheyne-Stokes breathing during sleep in LVF. Our findings that Cheyne-Stokes breathing predicts an adverse short-term mortality rate confirm the clinical impression that Cheyne-Stokes breathing is a poor prognostic sign in LVF.

Entities:  

Mesh:

Year:  1985        PMID: 3966165     DOI: 10.1097/00007611-198501000-00004

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  26 in total

Review 1.  Prognosis and sleep disordered breathing in heart failure.

Authors:  I Wilcox; S G McNamara; T Wessendorf; G N Willson; A J Piper; C E Sullivan
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

2.  Treatment of central sleep apnoea in congestive heart failure with nasal ventilation.

Authors:  G N Willson; I Wilcox; A J Piper; W E Flynn; R R Grunstein; C E Sullivan
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 3.  Impact of treatment of sleep apnoea on left ventricular function in congestive heart failure.

Authors:  M T Naughton
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 4.  Sleep in congestive heart failure.

Authors:  Bhavneesh Sharma; Robert Owens; Atul Malhotra
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

5.  The impact of positive airway pressure on cardiac status and clinical outcomes in patients with advanced heart failure and sleep-disordered breathing: a preliminary report.

Authors:  Apostolos Karavidas; Fotis Kapsimalis; George Lazaros; Evaggelos Markozanes; Sophia Arapi; Kiriaki Cholidou; Vassiliki Matzaraki; Konstantina Kyrkou; Dimitris Tsiachris; Evaggelos Matsakas; Vlassios Pyrgakis; Manos Alchanatis
Journal:  Sleep Breath       Date:  2010-10-02       Impact factor: 2.816

6.  Prevalence of Cheyne-Stokes respiration in modern treated congestive heart failure.

Authors:  Gerrit Hagenah; Dennis Beil
Journal:  Sleep Breath       Date:  2008-09-13       Impact factor: 2.816

7.  Prevalence and Characteristics of Central Compared to Obstructive Sleep Apnea: Analyses from the Sleep Heart Health Study Cohort.

Authors:  Lucas M Donovan; Vishesh K Kapur
Journal:  Sleep       Date:  2016-07-01       Impact factor: 5.849

Review 8.  Pathophysiology and treatment of Cheyne-Stokes respiration.

Authors:  M T Naughton
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

Review 9.  Epidemiology of Sleep-Disordered Breathing and Heart Failure: What Drives What.

Authors:  Sushma M Dharia; Lee K Brown
Journal:  Curr Heart Fail Rep       Date:  2017-10

10.  Cheyne-stokes respiration and prognosis in modern-treated congestive heart failure.

Authors:  Gerrit Hagenah; Antonia Zapf; Jan Bernd Schüttert
Journal:  Lung       Date:  2009-12-12       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.